Cierra N. Sharp

Cierra N. Sharp

Aug 16, 2016

Group 6 Copy 71
-4
    Please wait...

    About This Project

    A major dose-limiting toxicity of some chemotherapeutics (like cisplatin) is nephrotoxicity, leading to acute kidney injury (AKI) in 30% of patients. The aim of my project is to develop a mouse model that recapitulates the dosing regimen humans receive in order to develop and test novel renoprotective agents. This is important as there are no therapeutic interventions for cisplatin-induced AKI, and no long-term studies on kidney function have been performed in mice treated with cisplatin.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Genetic engineering of fungi for next generation sustainable tools

    Anthropogenic influence on the Earth has had a negative effect. We need to create a sustainable way of living...

    How are the repetitive circular DNA sequences present on chloroplasts created?

    The Inverted Sequence (IR) of some plants is one of well-known kind of special sequences. But, until now...

    Can we identify spawning events in deepwater snappers and groupers?

    Nearshore deepwater fisheries are expanding in the Caribbean as coastal fisheries decline. Because deepwater...

    Backer Badge Funded